These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36523928)

  • 41. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience.
    Liu CL; Fan ST; Lo CM; Tso WK; Poon RT; Lam CM; Wong J
    J Clin Oncol; 2001 Sep; 19(17):3725-32. PubMed ID: 11533094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-Fetoprotein+Alkaline Phosphatase (A-A) Score Can Predict the Prognosis of Patients with Ruptured Hepatocellular Carcinoma Underwent Hepatectomy.
    Xia F; Ndhlovu E; Liu Z; Chen X; Zhang B; Zhu P
    Dis Markers; 2022; 2022():9934189. PubMed ID: 35493302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic Left Hepatectomy for Ruptured Hepatocellular Carcinoma Controlled After Transcatheter Arterial Embolization: Case Report and Review of the Literature.
    Yoshiya S; Iwaki K; Sakai A; Fujita S; Kawasaki T; Yoshizumi F; Hiroshige S; Okamoto M; Fukuzawa K; Motohiro A; Maehara Y
    In Vivo; 2018; 32(3):659-662. PubMed ID: 29695575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergency versus delayed hepatectomy following transarterial embolization in spontaneously ruptured hepatocellular carcinoma survivors: a systematic review and meta-analysis.
    Zhang W; Huang Z; Che X
    World J Surg Oncol; 2022 Nov; 20(1):365. PubMed ID: 36397082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perioperative Outcomes of Laparoscopic Repeat Liver Resection for Recurrent HCC: Comparison with Open Repeat Liver Resection for Recurrent HCC and Laparoscopic Resection for Primary HCC.
    Goh BKP; Syn N; Teo JY; Guo YX; Lee SY; Cheow PC; Chow PKH; Ooi LLPJ; Chung AYF; Chan CY
    World J Surg; 2019 Mar; 43(3):878-885. PubMed ID: 30361747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study.
    Long L; Chen B; Wang H; Zhao Y; Wu F; Wang L; Rong W; Wu J; Li Y; Wang W
    Radiother Oncol; 2023 Mar; 180():109462. PubMed ID: 36634853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: A propensity matched analysis comparing ruptured versus non-ruptured tumors.
    Chua DW; Koh YX; Allen JC; Chan CY; Lee SY; Cheow PC; Jeyaraj P; Teo JY; Chow PK; Chung AY; Ooi LL; Goh BKP
    Eur J Surg Oncol; 2019 Sep; 45(9):1652-1659. PubMed ID: 31003720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group.
    Iaria M; Bianchi G; Fazio F; Ardito F; Perri P; Pontarolo N; Conci S; Donadon M; Zanello M; Lai Q; Famularo S; Molfino S; Sciannamea I; Fumagalli L; Germani P; Floridi A; Ferrari C; Zimmitti G; Troci A; Zago M; Ferraro V; Cipriani F; Patauner S; La Barba G; Romano M; Zanus G; Ercolani G; Frena A; Aldrighetti L; Memeo R; Pinotti E; Crespi M; Hilal MA; Griseri G; Tarchi P; Chiarelli M; Antonucci A; Baiocchi GL; Romano F; Rossi M; Jovine E; Torzilli G; Ruzzenente A; Maestri M; Grazi GL; Giuliante F; Ferrero A; Dalla Valle R;
    HPB (Oxford); 2022 Aug; 24(8):1291-1304. PubMed ID: 35125292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of primary tumor location with long-term oncological prognosis following hepatectomy for hepatocellular carcinoma:A multicenter propensity score matching analysis.
    Tang SC; Lin KY; Huang TF; Zhang KL; Kong J; He XL; Luo C; Chen QJ; Guo PF; Zhou WP; Zeng YY
    Eur J Surg Oncol; 2023 Jul; 49(7):1234-1241. PubMed ID: 36774217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MELD score is the better predictor for 30-day mortality in patients with ruptured hepatocellular carcinoma treated by trans-arterial embolization.
    Cheng YT; Teng W; Lui KW; Hsieh YC; Chen WT; Huang CH; Jeng WJ; Hung CF; Lin CC; Lin CY; Lin SM; Sheen IS
    Am J Cancer Res; 2021; 11(7):3726-3734. PubMed ID: 34354871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical impact of surgical treatment for the spontaneously ruptured resectable hepatocellular carcinoma: A single institution experience.
    Xu K; Ryu DH; Choi JW; Choi H; Kim DH; Lee TG; Kim MJ; Park S; Yoo KC
    Medicine (Baltimore); 2022 Sep; 101(35):e30307. PubMed ID: 36107587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of re-resection in recurrent hepatocellular carcinoma.
    Bednarsch J; Czigany Z; Heij LR; Amygdalos I; Heise D; Bruners P; Ulmer TF; Neumann UP; Lang SA
    Langenbecks Arch Surg; 2022 Sep; 407(6):2381-2391. PubMed ID: 35599252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
    Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
    J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
    Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
    BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma.
    Sada H; Ohira M; Kobayashi T; Tashiro H; Chayama K; Ohdan H
    Dig Surg; 2016; 33(1):43-50. PubMed ID: 26580332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy.
    Xiao H; Chen ZB; Jin HL; Li B; Xu LX; Guo Y; Chen SL; Li HP; Peng ZW; Shen JX
    Am J Transl Res; 2019; 11(3):1864-1875. PubMed ID: 30972210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.